Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 96.27
+0.37 (0.39%)
At close: Dec 5, 2025
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.36B CNY in the quarter ending September 30, 2025, with 42.03% growth. This brings the company's revenue in the last twelve months to 4.76B, up 48.49% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B with 76.29% growth.
Revenue (ttm)
4.76B
Revenue Growth
+48.49%
P/S Ratio
9.11
Revenue / Employee
3.36M
Employees
1,417
Market Cap
43.32B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |